Publisher
Springer Science and Business Media LLC
Subject
Economics and Econometrics,Sociology and Political Science
Reference97 articles.
1. Ackiron, E. (1991). Patents for critical pharmaceuticals: The AZT case. American Journal of Law and Medicine, 17(1–2), 145–180.
2. America's Health Insurance Plans. (2019). The rise of orphan drugs, AHIP, September.
3. Ardizzone, K. (2020). Role of the US federal government in the development of GS-5734/remdesivir. KEI Briefing Note, 2020, 1.
4. Arno, P. S., Bonuck, K., & Davis, M. (1995). Rare diseases, drug development and AIDS: The impact of Orphan Drug Act. The Milbank Quaterly, 73(2), 231–252.
5. Ashburn, T. T., & Thor, K. B. (2004). Drug repositioning: Identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery, 3, 673–684.